A component of innate immunity prevents bacterial biofilm development
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Antimicrobial factors form one arm of the innate immune system, which protects mucosal surfaces from bacterial infection. These factors can rapidly kill bacteria deposited on mucosal surfaces and prevent acute invasive infections. In many chronic infections, however, bacteria live in biofilms, which are distinct, matrix-encased communities specialized for surface persistence. The transition from a free-living, independent existence to a biofilm lifestyle can be devastating, because biofilms notoriously resist killing by host defence mechanisms and antibiotics. We hypothesized that the innate immune system possesses specific activity to protect against biofilm infections. Here we show that lactoferrin, a ubiquitous and abundant constituent of human external secretions, blocks biofilm development by the opportunistic pathogen Pseudomonas aeruginosa. This occurs at lactoferrin concentrations below those that kill or prevent growth. By chelating iron, lactoferrin stimulates twitching, a specialized form of surface motility, causing the bacteria to wander across the surface instead of forming cell clusters and biofilms. These findings reveal a specific anti-biofilm defence mechanism acting at a critical juncture in biofilm development, the time bacteria stop roaming as individuals and aggregate into durable communities.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Its iron-free form, apo-LF, inhibits the formation of biofilms by P. aeruginosa (Singh et al., 2002).”
From Iron in infection and immunity (2020) · cites this paper as Singh et al., 2002
In the citing paper
“The Fe-binding capacity of lactoferrin can also interfere with microbial virulence pathways such as biofilm formation [122].”
From The Iron age of host–microbe interactions (2015) · cites this paper as [122]
In the citing paper
“There are other examples, indicating a beneficial effect of targeting Fe, as illustrated for the ability of lactoferrin to prevent bacterial biofilm formation [122].”
From The Iron age of host–microbe interactions (2015) · cites this paper as [122]
Citations
Cites
Bacterial Biofilms: A Common Cause of Persistent Infections
Costerton, J. W., Stewart, P. S., & Greenberg, E. P. (1999) · Science · doi:10.1126/science.284.5418.1318 · Cited by 12,167
Self-citationThe Involvement of Cell-to-Cell Signals in the Development of a Bacterial Biofilm
Davies, D. G., Parsek, M. R., Pearson, J. P., Iglewski, B. H., Costerton, J. W., & Greenberg, E. P. (1998) · Science · doi:10.1126/science.280.5361.295 · Cited by 3,396 · cited 1×
“Methods Bacterial strains, plasmids, and growth conditions Pseudomonas aeruginosa strain PAO1 containing the GFP plasmid pMRP9-1 (ref”
BackgroundSelf-citationFlagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development
O'Toole, G. A., & Kolter, R. (1998) · Molecular Microbiology · doi:10.1046/j.1365-2958.1998.01062.x · Cited by 2,697
Phylogenetic Perspectives in Innate Immunity
Hoffmann, J. A., Kafatos, F. C., Janeway, C. A., & Ezekowitz, R. A. B. (1999) · Science · doi:10.1126/science.284.5418.1313 · Cited by 2,492 · cited 1×
“This led us to hypothesize that mucosal surfaces might possess an anti-biofilm defence, perhaps using antimicrobial factors, a phylogenetically conserved limb of the innate immune syste”
BackgroundQuorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms
Singh, P. K., Schaefer, A. L., Parsek, M. R., Moninger, T. O., Welsh, M. J., & Greenberg, E. P. (2000) · Nature · doi:10.1038/35037627 · Cited by 1,519 · cited 1×
“In many chronic infections, however, bacteria live in biofilms, which are distinct, matrix-encased communities specialized for surface persistenc”
BackgroundSelf-citationWeinberg, E. D. (1978) · Microbiological Reviews · doi:10.1128/mmbr.42.1.45-66.1978 · Cited by 1,254
Innate antimicrobial peptide protects the skin from invasive bacterial infection
Nizet, V., Ohtake, T., Lauth, X., Trowbridge, J., Rudisill, J., Dorschner, R. A., Pestonjamasp, V., Piraino, J., Huttner, K., & Gallo, R. L. (2001) · Nature · doi:10.1038/35106587 · Cited by 1,198 · cited 1×
“These factors can rapidly kill bacteria deposited on mucosal surfaces and prevent acute invasive infection”
BackgroundAlginate Overproduction Affects Pseudomonas aeruginosa Biofilm Structure and Function
Hentzer, M., Teitzel, G. M., Balzer, G. J., Heydorn, A., Molin, S., Givskov, M., & Parsek, M. R. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.18.5395-5401.2001 · Cited by 693 · cited 1×
“Pseudomonas aeruginosa biofilms for susceptibility tests were grown in a rotating disc reacto”
MethodSelf-citationThe Biochemistry of Desferrioxamine and its Relation to Iron Metabolism
Keberle, H. (1964) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1965.tb54077.x · Cited by 612
and the in vitroand in vivo biofilm mode of growth
Høiby, N., Krogh Johansen, H., Moser, C., Song, Z., Ciofu, O., & Kharazmi, A. (2001) · Microbes and Infection · doi:10.1016/s1286-4579(00)01349-6 · Cited by 356
Research works printed but not linked: 1
- Xiao, R. & Kisaalita, W. S. Iron acquisition from transferrin and lactoferrin by Pseudomonas aeruginosa pyoverdin. Microbiology 143, 2509–2515 (1997) · DOI · Paper page
Cited by
Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?
Brogden, K. A. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1098 · Cited by 5,829
“However, recognition that antimicrobial peptides have targets other than membranes, such as lactoferrin, which blocks biofilm development by opportunistic pathogen”
BackgroundHepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation
Ganz, T. (2003) · Blood · doi:10.1182/blood-2003-03-0672 · Cited by 1,544
Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen
Brooke, J. S. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.00019-11 · Cited by 1,434
Bahar, A., & Ren, D. (2013) · Pharmaceuticals · doi:10.3390/ph6121543 · Cited by 1,351
“[208], lactoferrin was found to block biofilm formation of P.”
BackgroundAttenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors
Hentzer, M. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg366 · Cited by 1,422
Lebeaux, D., Ghigo, J.-M., & Beloin, C. (2014) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00013-14 · Cited by 1,318
Beutler, B. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2003.10.005 · Cited by 1,276
“Lactoferrin alters the motility of certain bacteria, such as Pseudomonas aeruginosa, and their ability to form biofilms (Singh et al., 2002), and may help to cause their elimination.”
BackgroundA review of current and emergent biofilm control strategies
Simões, M., Simões, L. C., & Vieira, M. J. (2010) · LWT - Food Science and Technology · doi:10.1016/j.lwt.2009.12.008 · Cited by 1,231
“The increased biofilm resistance to conventional treatments enhances the need to develop new control strategies (Simões, Bennett, & Rosa, 2009; Singh et al., 2002).”
BackgroundGanoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota
Chang, C.-J., Lin, C.-S., Lu, C.-C., Martel, J., Ko, Y.-F., Ojcius, D. M., Tseng, S.-F., Wu, T.-R., Chen, Y.-Y. M., Young, J. D., et al. (2015) · Nature Communications · doi:10.1038/ncomms8489 · Cited by 1,249
Sociomicrobiology: the connections between quorum sensing and biofilms
Parsek, M. R., & Greenberg, E. P. (2005) · Trends in Microbiology · doi:10.1016/j.tim.2004.11.007 · Cited by 1,174
“Iron limitation has been previously shown to inhibit biofilm development [ 53 ].”
Self-citationEdwards, R., & Harding, K. G. (2004) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200404000-00004 · Cited by 1,099
Signals, Regulatory Networks, and Materials That Build and Break Bacterial Biofilms
Karatan, E., & Watnick, P. (2009) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00041-08 · Cited by 1,048
Tryptophan- and arginine-rich antimicrobial peptides: Structures and mechanisms of action
Chan, D. I., Prenner, E. J., & Vogel, H. J. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.04.006 · Cited by 1,039
“Even though its iron binding properties play a role in preventing biofilm formation [83], it is now known that this is not its only mechanism of action.”
BackgroundBiofilm formation by Pseudomonas aeruginosa wild type, flagella and type IV pili mutants
Klausen, M., Heydorn, A., Ragas, P., Lambertsen, L., Aaes‐Jørgensen, A., Molin, S., & Tolker‐Nielsen, T. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03525.x · Cited by 1,020
“Evidence has been presented that twitching motility may be stimulated by iron limitation (Singh et al., 2002), and that it may possibly be directed by chemical gradients (Darzins, 1994; Kearns and Shimkets, 1998; Kearns et al.”
BackgroundResultInfluentialActive Starvation Responses Mediate Antibiotic Tolerance in Biofilms and Nutrient-Limited Bacteria
Nguyen, D., Joshi-Datar, A., Lepine, F., Bauerle, E., Olakanmi, O., Beer, K., McKay, G., Siehnel, R., Schafhauser, J., Wang, Y., et al. (2011) · Science · doi:10.1126/science.1211037 · Cited by 978
Self-citationSchaible, U. E., & Kaufmann, S. H. E. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro1046 · Cited by 945
“The iron-sequestering function of LF has also been described as a vital, innate defence mechanism against Pseudomonas aeruginosa”
Strategies for combating bacterial biofilm infections
Wu, H., Moser, C., Wang, H.-Z., Høiby, N., & Song, Z.-J. (2015) · International Journal of Oral Science · doi:10.1038/ijos.2014.65 · Cited by 925
Jacobsen, S. M., Stickler, D. J., Mobley, H. L. T., & Shirtliff, M. E. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00019-07 · Cited by 814
“aeruginosa prevents biofilm formation through the stimulation of twitching motility (373).”
BackgroundHickman, J. W., Tifrea, D. F., & Harwood, C. S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507170102 · Cited by 836
Pathogen–Host Interactions in Pseudomonas aeruginosa Pneumonia
Sadikot, R. T., Blackwell, T. S., Christman, J. W., & Prince, A. S. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200408-1044so · Cited by 799
Iron and Pseudomonas aeruginosa biofilm formation
Banin, E., Vasil, M. L., & Greenberg, E. P. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504266102 · Cited by 801
Self-citationThe Multiple Signaling Systems Regulating Virulence in Pseudomonas aeruginosa
Nadal Jimenez, P., Koch, G., Thompson, J. A., Xavier, K. B., Cool, R. H., & Quax, W. J. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.05007-11 · Cited by 736
“aeruginosa infection model, iron availability and iron chelation via PVD play important roles in infection establishment (5, 180) and the development of chronic infections (141).”
BackgroundHuman Host Defense Peptide LL-37 Prevents Bacterial Biofilm Formation
Overhage, J., Campisano, A., Bains, M., Torfs, E. C. W., Rehm, B. H. A., & Hancock, R. E. W. (2008) · Infection and Immunity · doi:10.1128/iai.00318-08 · Cited by 696
“Increased surface motility would cause bacteria to wander across the surface instead of forming biofilms and is known to result in thin and flat biofilms without the mushroom-like structure (35, 49).”
BackgroundPseudomonas aeruginosa Twitching Motility: Type IV Pili in Action
Burrows, L. L. (2012) · Annual Review of Microbiology · doi:10.1146/annurev-micro-092611-150055 · Cited by 669
Self-generated diversity produces “insurance effects” in biofilm communities
Boles, B. R., Thoendel, M., & Singh, P. K. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407460101 · Cited by 670
Self-citationKaneko, Y., Thoendel, M., Olakanmi, O., Britigan, B. E., & Singh, P. K. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30783 · Cited by 661
Self-citationThe developmental model of microbial biofilms: ten years of a paradigm up for review
Monds, R. D., & O’Toole, G. A. (2009) · Trends in Microbiology · doi:10.1016/j.tim.2008.11.001 · Cited by 532
Leaky Gut As a Danger Signal for Autoimmune Diseases
Mu, Q., Kirby, J., Reilly, C. M., & Luo, X. M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00598 · Cited by 611
“Organized by its major component, a highly glycosylated gel-forming mucin MUC2, the mucus contains diverse molecules including IgA as well as enzymes and proteins, such as lactoferrin (18).”
BackgroundColvin, K. M., Gordon, V. D., Murakami, K., Borlee, B. R., Wozniak, D. J., Wong, G. C. L., & Parsek, M. R. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1001264 · Cited by 577
“The fate of new daughter cells were visually tracked and each cell was classified as an ‘‘aggregate builder’’ or ‘‘flyer’’ [28].”
BackgroundSelf-citationA dynamic and intricate regulatory network determines Pseudomonas aeruginosa virulence
Balasubramanian, D., Schneper, L., Kumari, H., & Mathee, K. (2013) · Nucleic Acids Research · doi:10.1093/nar/gks1039 · Cited by 591
“aeruginosa negating colonization and ultimately, biofilm formation (244,245).”
BackgroundKlausen, M., Aaes‐Jørgensen, A., Molin, S., & Tolker‐Nielsen, T. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03677.x · Cited by 556
“aeruginosa biofilms by preventing downregulation of twitching motility (Singh et al., 2002).”
BackgroundInfluentialPyoverdine siderophores: from biogenesis to biosignificance
Visca, P., Imperi, F., & Lamont, I. L. (2007) · Trends in Microbiology · doi:10.1016/j.tim.2006.11.004 · Cited by 544
Antimicrobial properties of lactoferrin
JENSSEN, H., & HANCOCK, R. (2009) · Biochimie · doi:10.1016/j.biochi.2008.05.015 · Cited by 509
Antimicrobial Peptides and Their Therapeutic Potential for Bacterial Skin Infections and Wounds
Pfalzgraff, A., Brandenburg, K., & Weindl, G. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00281 · Cited by 481
“Also lactoferrin increased twitching motility of P. aeruginosa by decreasing free iron levels due to chelating iron and thus is able to block biofilm development (Singh et al., 2002).”
BackgroundDéziel, E., Lépine, F., Milot, S., & Villemur, R. (2003) · Microbiology · doi:10.1099/mic.0.26154-0 · Cited by 496
“Interestingly, Singh et al. (2002) recently reported that very low available iron concentrations, resulting from sequestering, markedly stimulated surface motility, thus preventing biofilm development by P. aeruginosa.”
BackgroundType IV Pilin Proteins: Versatile Molecular Modules
Giltner, C. L., Nguyen, Y., & Burrows, L. L. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00035-12 · Cited by 472
Understanding, Monitoring, and Controlling Biofilm Growth in Drinking Water Distribution Systems
Liu, S., Gunawan, C., Barraud, N., Rice, S. A., Harry, E. J., & Amal, R. (2016) · Environmental Science & Technology · doi:10.1021/acs.est.6b00835 · Cited by 476
Role of biofilm in catheter-associated urinary tract infection☆
Trautner, B. W., & Darouiche, R. O. (2004) · American Journal of Infection Control · doi:10.1016/j.ajic.2003.08.005 · Cited by 455
“Conversely, adding lactoferrin, another host-derived iron-chelating agent, to cultures of P aeruginosa prevented the formation of cell clusters and biofilm.(86) Perhaps urinary catheters made from an iron-scavenging biomaterial would resist biofilm formation on their surfaces, but such catheters have not yet been deve…”
BackgroundLactoferrin a multiple bioactive protein: an overview
García-Montoya, I. A., Cendón, T. S., Arévalo-Gallegos, S., & Rascón-Cruz, Q. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.06.018 · Cited by 473
“Lf canbe isolated fromcow'smilkby variouspurificationmethods, or it can be expressed by recombinantmethods [51,71,185].”
Innate Immunity in the Respiratory Epithelium
Parker, D., & Prince, A. (2011) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2011-0011rt · Cited by 456
Microbial siderophores: a mini review
Saha, R., Saha, N., Donofrio, R. S., & Bestervelt, L. L. (2013) · Journal of Basic Microbiology · doi:10.1002/jobm.201100552 · Cited by 440
“Lactoferrin [151] and other synthetic iron chelators such as Conalbumin [195, 196], ferric picolinate, ferric acetohydroxamate [197], 2,20-dipyridyl (2DP), diethylenetriaminepentacetic acid (DTPA), EDTA, deferoxamine mesylate (DM) and ethylenediamine-N,N0diacetic acid (EDDA) [198] which compete with siderophores for b…”
Backgroundde la Fuente-Núñez, C., Korolik, V., Bains, M., Nguyen, U., Breidenstein, E. B. M., Horsman, S., Lewenza, S., Burrows, L., & Hancock, R. E. W. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00064-12 · Cited by 459
“Twitching motility has been shown to be involved in the disassembly of biofilm structures (45, 56).”
Quorum sensing in Pseudomonas aeruginosa biofilms
De Kievit, T. R. (2009) · Environmental Microbiology · doi:10.1111/j.1462-2920.2008.01792.x · Cited by 439
“, 2006; Duan and Surette, 2007) and several groups have reported a connection between iron availability and biofilm formation (Singh et al., 2002; Singh, 2004; Banin et al., 2005; Musk et al., 2005; Yang et al., 2007).”
BackgroundChua, S. L., Liu, Y., Yam, J. K. H., Chen, Y., Vejborg, R. M., Tan, B. G. C., Kjelleberg, S., Tolker-Nielsen, T., Givskov, M., & Yang, L. (2014) · Nature Communications · doi:10.1038/ncomms5462 · Cited by 421
“Bis-(30-50)-cyclic dimeric GMP (c-di-GMP) is an essential secondary messenger that many bacterial species employ in the control of biofilm formation and dispersal11.”
BackgroundLactoferrin: Multifunctional roles of lactoferrin: a critical overview
Ward, P. P., Paz, E., & Conneely, O. M. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5369-8 · Cited by 443
Genetic requirements for Staphylococcus aureus abscess formation and persistence in host tissues
Cheng, A. G., Kim, H. K., Burts, M. L., Krausz, T., Schneewind, O., & Missiakas, D. M. (2009) · The FASEB Journal · doi:10.1096/fj.09-135467 · Cited by 437
“Many bacterial species switch between planktonic growth and the formation of biofilms, thereby displaying increased antibiotic resistance (38), evasion from host immune defenses (39), or the ability to establish chronic infections in humans (40).”
BackgroundRetractedIncreased osteoblast and decreased Staphylococcus epidermidis functions on nanophase ZnO and TiO2
Colon, G., Ward, B. C., & Webster, T. J. (2006) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.30789 · Cited by 425
Ojha, A., Anand, M., Bhatt, A., Kremer, L., Jacobs, W. R., & Hatfull, G. F. (2005) · Cell · doi:10.1016/j.cell.2005.09.012 · Cited by 422
“However, we note that other biofilm-forming bacteria such as P. aeruginosa also require iron for biofilm growth (Singh et al., 2002) but do not encode a GroEL1-like protein.”
Bacterial ferrous iron transport: the Feo system
Lau, C. K. Y., Krewulak, K. D., & Vogel, H. J. (2016) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuv049 · Cited by 428
“Intriguingly, the iron-binding host defense protein lactoferrin can bind ferric iron and in doing so prevent biofilm formation (Singh et al. 2002).”
BackgroundBarken, K. B., Pamp, S. J., Yang, L., Gjermansen, M., Bertrand, J. J., Klausen, M., Givskov, M., Whitchurch, C. B., Engel, J. N., & Tolker‐Nielsen, T. (2008) · Environmental Microbiology · doi:10.1111/j.1462-2920.2008.01658.x · Cited by 418
“Lactoferrin was shown to inhibit the formation of microcolonies in P. aeruginosa biofilms by preventing downregulation of twitching motility (Singh et al., 2002).”
BackgroundPathogenesis of pneumonia and acute lung injury
Long, M. E., Mallampalli, R. K., & Horowitz, J. C. (2022) · Clinical Science · doi:10.1042/cs20210879 · Cited by 390
Single pilus motor forces exceed 100 pN
Maier, B., Potter, L., So, M., Seifert, H. S., & Sheetz, M. P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242523299 · Cited by 396
Walker, T. S., Bais, H. P., Déziel, E., Schweizer, H. P., Rahme, L. G., Fall, R., & Vivanco, J. M. (2004) · Plant Physiology · doi:10.1104/pp.103.027888 · Cited by 387
“Incidentally, P. aeruginosa biofilm inhibitors have been recently identified in human mucous secretions (Singh et al., 2002); thus, it might be possible to adapt our methods to screen root exudates for biofilm inhibitors.”
BackgroundBiofilm Matrix and Its Regulation in Pseudomonas aeruginosa
Wei, Q., & Ma, L. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141020983 · Cited by 369
“aeruginosa biofilm formation by chelating iron and stimulating the type IV pili-mediated twitching motility [124].”
BackgroundBiofilms and Antimicrobial Resistance
Patel, R. (2005) · Clinical Orthopaedics and Related Research · doi:10.1097/01.blo.0000175714.68624.74 · Cited by 390
Pseudomonas aeruginosa Biofilms: Host Response and Clinical Implications in Lung Infections
Maurice, N. M., Bedi, B., & Sadikot, R. T. (2018) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2017-0321tr · Cited by 373
“planktonic bacteria and thereby preventing attachment and microcolony formation (20).”
BackgroundAn update on Pseudomonas aeruginosa biofilm formation, tolerance, and dispersal
Harmsen, M., Yang, L., Pamp, S. J., & Tolker-Nielsen, T. (2010) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2010.00690.x · Cited by 376
“aeruginosa biofilms by iron limitation (Singh et al., 2002; Singh, 2004; Patriquin et al., 2008).”
BackgroundGoss, C. H., Kaneko, Y., Khuu, L., Anderson, G. D., Ravishankar, S., Aitken, M. L., Lechtzin, N., Zhou, G., Czyz, D. M., McLean, K., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aat7520 · Cited by 369
“In addition, in vitro work indicates that iron metabolism may be a particular vulnerability for organisms in biofilm-like aggregates found at sites of chronic infections in people with wounds, cystic fibrosis (CF), and other conditions (8).”
BackgroundSelf-citationLactoferrin: a natural Glycoprotein involved in iron and inflammatory homeostasis
Rosa, L., Cutone, A., Lepanto, M., Paesano, R., & Valenti, P. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091985 · Cited by 376
“[68] demonstrated another important iron-dependent Lf function: inhibition of Pseudomonas aeruginosa biofilm formation in cystic fibrosis (CF) by the iron-binding activity of Lf [68].”
BackgroundJesaitis, A. J., Franklin, M. J., Berglund, D., Sasaki, M., Lord, C. I., Bleazard, J. B., Duffy, J. E., Beyenal, H., & Lewandowski, Z. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.8.4329 · Cited by 368
“aeruginosa biofilms without inducing the dispersal of established biofilms (38).”
BackgroundInfluentialThe antimicrobial activity of lactoferrin: Current status and perspectives
Orsi, N. (2004) · Biometals · doi:10.1023/b:biom.0000027691.86757.e2 · Cited by 368
“First of all a reference should be made to a paper (Singh et al. 2002) underlining the role that lactoferrin can have in the innate immunity by blocking the biofilm development by the opportunistic pathogen Pseudomonas aeruginosa.”
Bacterial exo-polysaccharides in biofilms: role in antimicrobial resistance and treatments
Singh, S., Datta, S., Narayanan, K. B., & Rajnish, K. N. (2021) · Journal of Genetic Engineering and Biotechnology · doi:10.1186/s43141-021-00242-y · Cited by 331
“This signal is noteworthy because it is not of the homoserine lactone class [71].”
BackgroundIron in infection and immunity
Nairz, M., & Weiss, G. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2020.100864 · Cited by 359
Effects of iron on DNA release and biofilm development by Pseudomonas aeruginosa
Yang, L., Barken, K. B., Skindersoe, M. E., Christensen, A. B., Givskov, M., & Tolker-Nielsen, T. (2007) · Microbiology · doi:10.1099/mic.0.2006/004911-0 · Cited by 347
“aeruginosa biofilms in a flow-chamber system (Singh et al., 2002; Banin et al., 2005).”
InfluentialCowland, J. B., Sørensen, O. E., Sehested, M., & Borregaard, N. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.12.6630 · Cited by 354
Siderophore uptake in bacteria and the battle for iron with the host; a bird’s eye view
Chu, B. C., Garcia-Herrero, A., Johanson, T. H., Krewulak, K. D., Lau, C. K., Peacock, R. S., Slavinskaya, Z., & Vogel, H. J. (2010) · BioMetals · doi:10.1007/s10534-010-9361-x · Cited by 339
“…extremely low iron concentrations that are created by the presence of lactoferrin, prevent bacteria from aggregating with each other and forming biofilms (Singh et al. 2002); by keeping the bacteria in a planktonic state they are more susceptible to endogenous and exogenous antimicrobial compounds.”
BackgroundPutative Exopolysaccharide Synthesis Genes Influence Pseudomonas aeruginosa Biofilm Development
Matsukawa, M., & Greenberg, E. P. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.14.4449-4456.2004 · Cited by 336
“conditions have been described elsewhere (29).”
Self-citationMulti-species biofilms: how to avoid unfriendly neighbors
Rendueles, O., & Ghigo, J.-M. (2012) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2012.00328.x · Cited by 310
“For instance, lactoferrin is a protein naturally produced by humans which, at physiological concentrations, does not affect bacterial viability but reduces P. aeruginosa biofilms by chelating environmental iron (Singh et al., 2002).”
BackgroundBorges, A., Abreu, A., Dias, C., Saavedra, M., Borges, F., & Simões, M. (2016) · Molecules · doi:10.3390/molecules21070877 · Cited by 308
“This is supported by previous studies where it was suggested that iron sensing is mainly involved in the first steps of biofilm formation (cell attachment and microcolony formation), as they are vital for bacterial cell growth and adherence [226,227].”
MethodQuorum Quenching by an N -Acyl-Homoserine Lactone Acylase from Pseudomonas aeruginosa PAO1
Sio, C. F., Otten, L. G., Cool, R. H., Diggle, S. P., Braun, P. G., Bos, R., Daykin, M., Cámara, M., Williams, P., & Quax, W. J. (2006) · Infection and Immunity · doi:10.1128/iai.74.3.1673-1682.2006 · Cited by 322
“aeruginosa PAO1 was observed at concentrations of lactoferrin that did not inhibit growth (43).”
BackgroundControl of Biofilm Formation: Antibiotics and Beyond
Algburi, A., Comito, N., Kashtanov, D., Dicks, L. M. T., & Chikindas, M. L. (2017) · Applied and Environmental Microbiology · doi:10.1128/aem.02508-16 · Cited by 299
Characterization of Colony Morphology Variants Isolated from Pseudomonas aeruginosa Biofilms
Kirisits, M. J., Prost, L., Starkey, M., & Parsek, M. R. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.8.4809-4821.2005 · Cited by 290
Self-citationMolecular and Antibiofilm Approaches to Prosthetic Joint Infection
Trampuz, A., Osmon, D. R., Hanssen, A. D., Steckelberg, J. M., & Patel, R. (2003) · Clinical Orthopaedics and Related Research · doi:10.1097/01.blo.0000087324.60612.93 · Cited by 293
The biogeography of polymicrobial infection
Stacy, A., McNally, L., Darch, S. E., Brown, S. P., & Whiteley, M. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2015.8 · Cited by 294
Human calprotectin is an iron-sequestering host-defense protein
Nakashige, T. G., Zhang, B., Krebs, C., & Nolan, E. M. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1891 · Cited by 291
Inactivation of a Pseudomonas aeruginosa quorum-sensing signal by human airway epithelia
Chun, C. K., Ozer, E. A., Welsh, M. J., Zabner, J., & Greenberg, E. P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308750101 · Cited by 290
Self-citationLi, X., Qi, M., Sun, X., Weir, M. D., Tay, F. R., Oates, T. W., Dong, B., Zhou, Y., Wang, L., & Xu, H. H. K. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.06.023 · Cited by 279
Adlerova, L., Bartoskova, A., & Faldyna, M. (2008) · Veterinární medicína · doi:10.17221/1978-vetmed · Cited by 280
“Therefore, they cannot adhere to surfaces (Singh et al., 2002).”
Current and Recent Advanced Strategies for Combating Biofilms
Sadekuzzaman, M., Yang, S., Mizan, M. F. R., & Ha, S. D. (2015) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12144 · Cited by 276
A structural framework for understanding the multifunctional character of lactoferrin
BAKER, E., & BAKER, H. (2009) · Biochimie · doi:10.1016/j.biochi.2008.05.006 · Cited by 279
“Other properties also stem from its iron binding ability, for example its inhibition of biofilm formation [68].”
BackgroundAntimicrobial peptides: natural effectors of the innate immune system
Radek, K., & Gallo, R. (2007) · Seminars in Immunopathology · doi:10.1007/s00281-007-0064-5 · Cited by 275
CFTR Expression in Human Neutrophils and the Phagolysosomal Chlorination Defect in Cystic Fibrosis
Painter, R. G., Valentine, V. G., Lanson, Leidal, K., Zhang, Q., Lombard, G., Thompson, C., Viswanathan, A., Nauseef, W. M., Wang, G., et al. (2006) · Biochemistry · doi:10.1021/bi060490t · Cited by 269
Botha, P., Archer, L., Anderson, R. L., Lordan, J., Dark, J. H., Corris, P. A., Gould, K., & Fisher, A. J. (2008) · Transplantation · doi:10.1097/tp.0b013e31816651de · Cited by 274
“Defective iron homeostasis with a decreased availability of lactoferrin, a natural bacteriostatic agent of the innate immune system, has been implicated in the development of chronic infection in those with CF (8).”
BackgroundIron-withholding strategy in innate immunity
Ong, S. T., Shan Ho, J. Z., Ho, B., & Ding, J. L. (2006) · Immunobiology · doi:10.1016/j.imbio.2006.02.004 · Cited by 269
“Singh et al. (2002) also demonstrated that lactoferrin stimulates twitching, a specialized form of surface motility by chelating iron, causing the Pseudomonas aeruginosa to wander around instead of forming clusters and biofilms.”
BackgroundInfluentialControlling the release of peptide antimicrobial agents from surfaces
Shukla, A., Fleming, K. E., Chuang, H. F., Chau, T. M., Loose, C. R., Stephanopoulos, G. N., & Hammond, P. T. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2009.11.082 · Cited by 265
Identification of Proteins Associated with the Pseudomonas aeruginosa Biofilm Extracellular Matrix
Toyofuku, M., Roschitzki, B., Riedel, K., & Eberl, L. (2012) · Journal of Proteome Research · doi:10.1021/pr300395j · Cited by 262
Lactoferrin and iron: Structural and dynamic aspects of binding and release
Baker, H. M., & Baker, E. N. (2004) · Biometals · doi:10.1023/b:biom.0000027694.40260.70 · Cited by 265
“Finally a recent report identifies Lf as an inhibitor of biofilm formation by pathogenic Pseudomonas aeruginosa, through iron sequestration ( Singh et al. 2002 ).”
BackgroundLactoferrin, a bird’s eye view
Vogel, H. J. (2012) · Biochemistry and Cell Biology · doi:10.1139/o2012-016 · Cited by 260
Enhanced Pseudomonas aeruginosa Biofilm Development Mediated by Human Neutrophils
Walker, T. S., Tomlin, K. L., Worthen, G. S., Poch, K. R., Lieber, J. G., Saavedra, M. T., Fessler, M. B., Malcolm, K. C., Vasil, M. L., & Nick, J. A. (2005) · Infection and Immunity · doi:10.1128/iai.73.6.3693-3701.2005 · Cited by 263
“Recently, purified lactoferrin, a major component of the secondary neutrophil granules, was found to prevent P. aeruginosa biofilm development ( 39 ).”
BackgroundLebeer, S., Verhoeven, T. L. A., Perea Vélez, M., Vanderleyden, J., & De Keersmaecker, S. C. J. (2007) · Applied and Environmental Microbiology · doi:10.1128/aem.01393-07 · Cited by 259
“The iron-chelating peptide lactoferrin, expressed by glandular epithelial cells and neutrophils, was recently reported to block biofilm development on mucosal surfaces by the opportunistic pathogen Pseudomonas aeruginosa (concentration tested, 20 g/ml) (42).”
BackgroundThe potential of desferrioxamine-gallium as an anti- Pseudomonas therapeutic agent
Banin, E., Lozinski, A., Brady, K. M., Berenshtein, E., Butterfield, P. W., Moshe, M., Chevion, M., Greenberg, E. P., & Banin, E. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808608105 · Cited by 258
“aeruginosa biofilm formation (9, 10), that Ga has anti-biofilm activity (4), and that P.”
BackgroundSelf-citationThe immune system vs.Pseudomonas aeruginosa biofilms
Jensen, P. Ø., Givskov, M., Bjarnsholt, T., & Moser, C. (2010) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2010.00706.x · Cited by 251
Flagella and Pili-Mediated Near-Surface Single-Cell Motility Mechanisms in P. aeruginosa
Conrad, J. C., Gibiansky, M. L., Jin, F., Gordon, V. D., Motto, D. A., Mathewson, M. A., Stopka, W. G., Zelasko, D. C., Shrout, J. D., & Wong, G. C. L. (2011) · Biophysical Journal · doi:10.1016/j.bpj.2011.02.020 · Cited by 248
Kai-Larsen, Y., Lüthje, P., Chromek, M., Peters, V., Wang, X., Holm, Å., Kádas, L., Hedlund, K.-O., Johansson, J., Chapman, M. R., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001010 · Cited by 251
“Both LL-37 [46] and lactoferrin [47] increased bacterial surface motility mediated by”
BackgroundIron metabolism and the innate immune response to infection
Johnson, E. E., & Wessling-Resnick, M. (2012) · Microbes and Infection · doi:10.1016/j.micinf.2011.10.001 · Cited by 253
“The capacity of lactoferrin to sequester iron also has been implicated in the ability of patients with cystic fibrosis to control opportunistic Pseudomonas aeruginosa infection and biofilm formation [17;18].”
BackgroundHuang, Z., Weng, Y., Shen, Q., Zhao, Y., & Jin, Y. (2021) · Science of The Total Environment · doi:10.1016/j.scitotenv.2021.147365 · Cited by 244
Inhaled formulations and pulmonary drug delivery systems for respiratory infections
Zhou, Q. (., Leung, S. S. Y., Tang, P., Parumasivam, T., Loh, Z. H., & Chan, H.-K. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.10.022 · Cited by 246
Jin, Y., Yip, H. K., Samaranayake, Y. H., Yau, J. Y., & Samaranayake, L. P. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.7.2961-2967.2003 · Cited by 254
Matsui, H., Wagner, V. E., Hill, D. B., Schwab, U. E., Rogers, T. D., Button, B., Taylor, R. M., Superfine, R., Rubinstein, M., Iglewski, B. H., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606428103 · Cited by 245
A study of biofilm-based wound management in subjects with critical limb ischaemia
Wolcott, R. D., & Rhoads, D. D. (2008) · Journal of Wound Care · doi:10.12968/jowc.2008.17.4.28835 · Cited by 243
Metadata
- Authors
- Singh, P. K., Parsek, M. R., Greenberg, E. P., & Welsh, M. J.
- Affiliations
- University of Iowa (US)
- Northwestern University (US)
- Corresponding author
- Singh, Pradeep K.
- Venue
- Nature
- Published
- 2002-05
- Volume
- 417
- Issue
- 6888
- Pages
- 552-555
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1970294462
- Cited by
- 1,026
- References
- 31
- Citations by year
- 2026: 20 · 2025: 19 · 2024: 24 · 2023: 35 · 2022: 34 · 2021: 45 · 2020: 37 · 2019: 33 · 2018: 43 · 2017: 43 · 2016: 43 · 2015: 52 · 2014: 55 · 2013: 37 · 2012: 69
- FWCI
- 16.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Heart, Lung, and Blood Institute (K24HL102246)
- National Institute of General Medical Sciences
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Life Sciences › Immunology and Microbiology › Microbiology › Antimicrobial Peptides and Activities
- Life Sciences › Immunology and Microbiology › Microbiology › Escherichia coli research studies
- Keywords
- lactoferrin, bacterial biofilm formation, Pseudomonas aeruginosa, innate immunity, iron chelation, twitching motility, surface motility, mucosal protection, chronic bacterial infection
- MeSH terms
- Chronic Disease, Conalbumin, Dose-Response Relationship, Drug, Humans, Hydrogen Peroxide, Immunity, Innate, Iron, Iron Chelating Agents, Lactoferrin, Pseudomonas aeruginosa, Tobramycin, Biofilms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.